01 3ABBVIE
01 38686026
01 3Blank
01 3Y
01 32031-06-09
Patent Expiration Date : 2031-06-09
DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
US Patent Number : 8686026
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208624
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-09
Patent Expiration Date : 2031-06-09
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
US Patent Number : 8686026
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206619
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-09
Patent Expiration Date : 2031-06-09
OMBITASVIR; PARITAPREVIR; RITONAVIR
US Patent Number : 8686026
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207931
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-06-09
